D59.2
Drug-induced nonautoimmune hemolytic anemia
HCC risk adjustment mapping
CMS-HCC ESRD V24
Severe Hematological Disorders
RxHCC V08
Acquired Hemolytic, Aplastic, and Sideroblastic Anemias
Coding notes
Excludes 1 never coded together · Excludes 2 may co-exist
code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5)
Drug-induced enzyme deficiency anemia
autoimmune disease (systemic) NOS (M35.9) certain conditions originating in the perinatal period (P00-P96) complications of pregnancy, childbirth and the puerperium (O00-O9A) congenital malformations, deformations and chromosomal abnormalities (Q00-Q99) endocrine, nutritional and metabolic diseases (E00-E88) human immunodeficiency virus [HIV] disease (B20) injury, poisoning and certain other consequences of external causes (S00-T88) neoplasms (C00-D49) symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00-R94)
Official Guidelines for D59.2
FY 2026 ›Sections that reference D59.2
- I.C.1.a.2)(b)Patient admitted for HIV-related conditionChapter 1
… Assign code D59.31, Infection-associated hemolytic-uremic syndrome, followed by code B20, Human immunodeficiency virus [HIV] disease.
- I.C.1.d.9)Hemolytic-uremic syndrome associated with sepsisChapter 1
If the reason for admission is hemolytic-uremic syndrome that is associated with sepsis, assign code D59.31, Infection-associated hemolytic-uremic syndrome, as the principal diagnosis. …
Sections whose FY 2026 text names D59.2, its D59 category, or a range containing it — the chapter guidance above is the authoritative source.
Find D59.2 in the alphabetic index
7 index paths lead to this code
- Anemia › enzyme-deficiency, drug-induced
- Nonautoimmune hemolytic anemia › drug-induced
- Disease, diseased › nonautoimmune hemolytic › drug-induced
- Anemia › deficiency › enzyme › drug-induced
- Anemia › hemolytic › due to › drugs
- Anemia › hemolytic › nonautoimmune › drug-induced
- Anemia › hemolytic › due to › enzyme disorder › drug-induced